Get our lovely INSIGHT 2019 conference news


Email address
First Name
Last Name
Interested in InSight 2019
Cart
<We_can_help/>

What are you looking for?

<Good_things_happen/> Welcome to Conference

Psychedelic therapy – how much psychotherapy is part of it?

Over the course of the long and interesting history of therapeutic use of psychedelics, various therapeutic settings and approaches emerged, spanning from shamanistic rituals to modern, manualized treatment sessions on a psychotherapeutic basis. Novel therapeutic settings in recent studies, which make the claim for integrating psychotherapeutic approaches, use elements of different psychotherapeutic directions in an eclectic way. Both aspects of modern behavioral and psychodynamic therapy found their way into the treatment sessions. Behavioral aspects include classical cognitive behavioral elements like motivational interviewing, as well as third wave therapies such as Acceptance and Commitment Therapy (ACT) or Mindfulness Based approaches. On the other hand, psychodynamic elements can be found in terms of working with dream-like states as a way to the subconscious, reducing psychological resistance, eliciting free association, insight and catharsis, and intensifying transference.
Furthermore, several common factors of psychotherapy can be found, such as high priority of a therapeutic alliance or substance-specific properties, e.g. increased suggestibility, or highly affective states like the psychedelic peak experience.
In this talk, Dr. Michael Koslowski, a therapist with a psychodynamic background and Dr. Felix Betzler, a behavioral therapist, will explore the range of therapeutic aspects of psychedelic therapy from two different perspectives.

Speaker

Date

September 6th 2019

Time

14:35-15:00

Location

Room: Rudolf Virchow
tickets
Felix Betzler
Dr. med.

Felix Betzler

Clinic for psychiatry and psychotherapy, Charité - University Medicine Berlin; Specialist more about the speaker
Michael Koslowski
Dr. med.

Michael Koslowski

Clinic for psychiatry and psychotherapy, Charité - University Medicine Berlin; Specialist more about the speaker

Related Events

Psychedelic therapy – how much psychotherapy is part of it?

Over the course of the long and interesting history of therapeutic use of psychedelics, various therapeutic settings and approaches emerged, spanning from shamanistic rituals to modern, manualized treatment sessions on a psychotherapeutic basis. Novel therapeutic settings in recent studies, which make the claim for integrating psychotherapeutic approaches, use elements of different psychotherapeutic directions in an eclectic way. Both aspects of modern behavioral and psychodynamic therapy found their way into the treatment sessions. Behavioral aspects include classical cognitive behavioral elements like […]

more details

Psilocybin-Assisted Treatment of Alcohol Use Disorder: Historical Context and Current Clinical Research

The use of classic psychedelics in the treatment of alcohol use disorder dates to Hoffer and Osmond’s work with LSD in Saskatchewan starting in 1953. Initially seen as a way to safely induce a delirium tremens-like experience, LSD was tested in clinical trials and used in treatment programs for thousands of patients through the early 1970s, resulting in substantial but inconclusive evidence for its effectiveness. With increasing restriction of access to psychedelics for reach purposes, LSD research ceased in the […]

more details

Phenomenology of the ketamine experience, reports from Ketamine Assisted Psychotherapy (KAP)

Ketamine is unique from the known and loved phenethylamines, tryptamines, and ergolines (all Schedule 1 drugs in the U.S. and highly controlled), which tend exert their effects by interacting with serotonin, dopamine, and/or norepinephrine receptors. Ketamine is classified as a dissociative anesthetic and is listed as a Schedule III drug in the United States. It has a novel mechanism of action as a N-methyl-D-aspartate (NMDA) receptor antagonist. In addition, its effects can be quite different from the more typical hallucinogens/psychedelics/entheogens […]

more details

Conference tickets

With your ticket you will have access to the whole conference - with keynotes, panels, round tables, posters and daylight social events. We will ask for a small extra fee for the Friday evening social program. The pre-conference workshops have to be booked separately and each workshop needs an individual ticket. By clicking on "Book now" below you also have the option to buy your workshop tickets.

*Reduced fees apply to students, cooperation partners as well as unemployed and retired individuals who have a monthly net income below 840,- €. Proof of status will be required.

Early bird

until 14 April 2019

  • Standard €170
  • Reduced €80*
  • MIND members Standard €100
  • MIND members Reduced €50

Regular

after 14 April 2019

  • Standard €250
  • Reduced €150*
  • MIND members Standard €180
  • MIND members Reduced €90

Philanthropist

 

  • Donate €600 or more
  • Invite a friend/colleague to be your VIP guest at the event

Get our lovely INSIGHT 2019 conference news


Email address
First Name
Last Name